BridgeMD
New treatment option for Borderline Personality Disorder
Official title SHame prOpensity in bOrderline Personality Disorder
ClinicalTrials.gov ID: NCT03994510
What this study is testing
- What it's testing
- Borderline Personality Disorder (BPD) is a common psychiatric disorder occurring in 2 to 6% of the population. 70% of patients with BPD do at least one Suicide Attempt (SA) in their lives.
- Time commitment: about 5 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- To be over 18
- Clinical diagnosis of BPD using the SCID II (Structured Clinical Interview for DSM-IV-Text Reviewed Axis II Personality Disorders)
- Having signed the informed consent
- Able to understand the nature, the purpose and the methodology of the study
- Able to understand and perform the clinical evaluations
You likely can't join if
- Deprived of liberty (by judicial or administrative decision)
- Protected by law (guardianship)
- Exclusion period in relation to another protocol
- Not affiliated to a social security scheme
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, Hérault, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 5 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, Hérault, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.